Improving Outcomes in Patients With Molecularly Altered NSCLC Through Broad Implementation of Precision Testing and Treatment:
Cureus | The Utility of Next-Generation Sequencing in the Treatment Decision-Making for Metastatic Non-Small-Cell Lung Cancer | Article
Optimizing Biomarker Testing in Advanced Non-Small Cell Lung Cancer - Cancer Therapy Advisor
Frontiers | Practical Considerations Relating to Routine Clinical Biomarker Testing for Non–small Cell Lung Cancer: Focus on Testing for RET Fusions
JMP | Free Full-Text | Liquid Biopsy for Biomarker Testing in Non-Small Cell Lung Cancer: A European Perspective
The basics of commonly used molecular techniques for diagnosis, and application of molecular testing in cytology - Turner - 2023 - Diagnostic Cytopathology - Wiley Online Library
Diagnostics | Free Full-Text | The Role of the Pathologist in the Next-Generation Era of Tumor Molecular Characterization
Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for
From Traditional Histology to Next-Generation Pathology: A Review of The Workflow for the Characterisation and Molecular Profiling of Non-Small Cell Lung Cancer Samples - European Medical Journal
Full article: Profile of Ventana ALK (D5F3) companion diagnostic assay for non-small-cell lung carcinomas
Improving Outcomes in Anaplastic Lymphocyte Kinase-Positive Metastatic Non-Small Cell Lung Cancer - Cancer Therapy Advisor
PDF) LYNX (LYmphoid NeXt-generation sequencing) panel: a comprehensive capture-based sequencing tool for the analysis of prognostic and predictive markers in lymphoid malignancies
Oncogenic Drivers in Advanced NSCLC: Navigating an Evolving Landscape to Optimise Patient Outcomes - European Medical Journal
Authors' Reply
Diagnostics | Free Full-Text | RNA-Based Multiplexing Assay for Routine Testing of Fusion and Splicing Variants in Cytological Samples of NSCLC Patients
Navigating the Complexities of Molecular Testing for EGFR Mutations to Guide Treatment Selection in Lung Cancer: Evidence, Practicalities, and Implications for Pathologists
Comparison of solid tissue sequencing and liquid biopsy accuracy in identification of clinically relevant gene mutations and rearrangements in lung adenocarcinomas - Modern Pathology
Cytopathology in focus: Updated NSCLC guideline moves molecular cytopathology forward
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibi
Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines
PDF) Validity of Targeted Next-Generation Sequencing in Routine Care for Identifying Clinically Relevant Molecular Profiles in Non-Small-Cell Lung Cancer: Results of a 2-Year Experience on 1343 Samples
Improving Molecular Testing in Lung Cancer: What We Learned From the IASLC Global Survey - ILCN.org (ILCN/WCLC)
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of
